Precision Cancer Medicine
Search All News
Spotlighting new research from the Momen-Heravi lab on immunotherapy response in head and neck cancer and other solid tumor types.
A new study by Elham Azizi and Ben Izar shows a new technique to study cancer tissues archived in biobanks, increasing the variety of samples for analysis and the discovery of biomarkers.
Exciting new clinical investigations, including results of the ALPINE study, show promising, more effective treatment for patients with CLL.
- October 19, 2022
The CZI Diversity award recognizes the Azizi lab with a new $1.15M grant and underscores Dr. Azizi's commitment to improving diversity and inclusion in cancer science, engineering, and research.
- October 6, 2022
A congratulations to Dr. Gaublomme who has received a prestigious NIH Director's New Innovator Award for work that pushes the boundaries in cancer research.
- August 12, 2022
Which patients respond less well to radiation therapy and why? Find out how the Spina lab is approaching this problem from the perspective of the immune system.
Source:CUIMC NewsroomAugust 5, 2022
Angela Christiano's groundbreaking research in alopecia areata led to the first FDA-approved systemic treatment for the autoimmune disease, and could also point the way to new cancer therapies.
- July 12, 2022
Annual Precision Medicine Pilot Grants are awarded to five Columbia research teams, including research led by members Drs. Brent Stockwell and Kelley Yan.
Source:Columbia NewsJune 15, 2022
"In the next wave of precision medicine, treating cancer will depend on our ability to be even more predictive with our approaches," writes Dr. Andrea Califano in our latest Disruptors column.
- April 29, 2022
Expert geneticist Dr. Wendy Chung takes us through the ever-evolving genetics landscape and its revolutionary impact in cancer.